Literature DB >> 3999313

M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus.

A V Klinkhoff, C R Thompson, G D Reid, C W Tomlinson.   

Abstract

A prospective clinical and echocardiographic study of 47 patients with systemic lupus erythematosus (SLE) and 46 age- and sex-matched controls showed an increased prevalence of echocardiographic abnormalities in the SLE group. Pericardial abnormalities were identified in ten patients with SLE and in no controls. Excluding mitral valve prolapse, valvular abnormalities were identified in ten patients with SLE (21%) and in three controls (7%). In the patients with SLE, abnormalities included mitral valve leaflet thickening in six, aortic valve thickening in five, and mitral annular calcification in two. The presence of valvular abnormalities correlated with duration but not with severity of SLE. The finding of systolic murmurs in 17 of 47 patients with SLE did not correlate with echocardiographic evidence of valvular disease. In six patients with SLE, valvular abnormalities detected by two-dimensional echocardiography were not seen on M-mode echocardiogram.

Entities:  

Mesh:

Year:  1985        PMID: 3999313

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

Review 1.  Cardiac valvulopathy in the antiphospholipid syndrome.

Authors:  Shaul Lev; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

2.  Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.

Authors:  O Meyer; M Golstein; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

3.  Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.

Authors:  R A Asherson; M Tikly; H Staub; P T Wilmshurst; D J Coltart; M Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

4.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.

Authors:  M G Tektonidou; J P Ioannidis; I Moyssakis; K A Boki; V Vassiliou; P G Vlachoyiannopoulos; M K Kyriakidis; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

6.  Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.

Authors:  Piotr Leszczyński; Ewa Straburzyńska-Migaj; Izabela Korczowska; Jan K Łacki; Stefan Mackiewicz
Journal:  Clin Rheumatol       Date:  2003-10-14       Impact factor: 2.980

7.  Echocardiographic findings in patients with primary Sjögren's syndrome.

Authors:  S Rantapää-Dahlqvist; C Backman; H Sandgren; Y Ostberg
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 8.  Cardiorheumatology: cardiac involvement in systemic rheumatic disease.

Authors:  Megha Prasad; Joerg Hermann; Sherine E Gabriel; Cornelia M Weyand; Sharon Mulvagh; Rekha Mankad; Jae K Oh; Eric L Matteson; Amir Lerman
Journal:  Nat Rev Cardiol       Date:  2014-12-23       Impact factor: 32.419

9.  Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle.

Authors:  M A Coppock; R E Safford; G K Danielson
Journal:  Br Heart J       Date:  1988-11

10.  Severe Bioprosthetic Mitral Valve Stenosis and Heart Failure in a Young Woman with Systemic Lupus Erythematosus.

Authors:  Siddharth Wartak; Isaac Akkad; Adnan Sadiq; Gregory Crooke; Manfred Moskovits; Robert Frankel; Gerald Hollander; Jacob Shani
Journal:  Case Rep Cardiol       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.